Information for Clinicians on Therapeutic Options for COVID-19 Patients
Posted by Associated Press on 22nd March 2020
| 38 views

link to original article

There are no US Food and Drug Administration (FDA)-approved drugs specifically for the treatment of patients with COVID-19. At present clinical management includes infection prevention and control measures and supportive care, including supplementary oxygen and mechanical ventilatory support when indicated. An array of drugs approved for other indications as well as several investigational drugs are being studied in several hundred clinical trials that are underway across the globe. The purpose of this document is to provide information on two of the approved drugs (chloroquine and hydroxychloroquine) and one of the investigational agents (remdesivir) currently in use in the United States.

This news article was originally published on CDC News

Please disable your AdBlocker so our free service can continue delivering you breaking news, insightful analysis, and a collection of aggregated content that will keep you informed like no other.